Sleep Hygiene

Sleep hygiene in psychiatric care is a structured set of behavioral, environmental, and circadian interventions designed to restore the consolidated, restorative sleep that mood, anxiety, and trauma disorders consistently disrupt. At RECO Immersive in Delray Beach, our team treats sleep as a primary clinical target — not an afterthought — because untreated sleep disturbance independently worsens depression, blunts antidepressant response, and increases relapse risk. Our protocols include consistent sleep-wake timing, morning light exposure, evening blue-light reduction, stimulus control (bed reserved for sleep), caffeine and alcohol modification, room temperature optimization between 65 and 68 degrees, and pre-sleep wind-down rituals. We layer these foundational changes onto Cognitive Behavioral Therapy for Insomnia (CBT-I), the first-line evidence-based treatment for chronic insomnia.

Sleep is the period when the brain clears metabolic waste through the glymphatic system, consolidates emotional memories in REM, and resets the hypothalamic-pituitary-adrenal axis that drives the stress response. Without adequate slow-wave and REM sleep, emotional regulation falters, the amygdala becomes hyper-reactive, and prefrontal control weakens — the exact neurobiological signature seen in major depressive disorder and generalized anxiety. Research shows that residual insomnia after antidepressant treatment is the single strongest predictor of depressive relapse. At RECO Immersive, we view sleep restoration as a non-negotiable foundation: our patients respond better to TMS, medication adjustments, and trauma therapy when their sleep architecture is repaired first.

Sleep disturbance presents differently across diagnoses, and our psychiatrists tailor treatment accordingly. Major depressive disorder typically presents with early-morning awakening, reduced REM latency, and fragmented slow-wave sleep. Bipolar disorder cycles between insomnia during mania and hypersomnia during depressive phases — disrupted sleep is often the earliest mood-episode warning sign. Generalized anxiety produces difficulty initiating sleep due to cognitive arousal, while PTSD generates fragmented sleep, frequent awakenings, and nightmares tied to trauma reconsolidation failure. ADHD often involves delayed sleep phase, and OCD can produce ritual-driven sleep avoidance. RECO Immersive’s diagnostic intake maps your specific sleep phenotype before designing the intervention.

Cognitive Behavioral Therapy for Insomnia (CBT-I) is the gold-standard, first-line treatment for chronic insomnia and is offered at RECO Immersive as part of our integrated treatment plans. CBT-I combines five components: sleep restriction therapy (compressing time in bed to consolidate sleep drive), stimulus control (re-associating the bed with sleep), cognitive restructuring of catastrophic thoughts about sleep loss, relaxation training, and sleep hygiene education. Clinical trials show CBT-I produces sleep improvements equivalent to or better than hypnotic medications — without dependence risk — and the gains persist long after treatment ends. Our therapists deliver CBT-I in roughly six to eight structured sessions, often integrated alongside medication management and psychiatric care.

Yes — RECO Immersive uses objective sleep monitoring to make treatment decisions based on data rather than recall. Patients can use wrist-worn actigraphy or consumer-grade trackers (Oura, WHOOP, Apple Watch) to capture continuous sleep-wake patterns, total sleep time, sleep efficiency, and movement-based estimates of sleep stages. This data reveals patterns the patient cannot reliably self-report — such as fragmented micro-awakenings, delayed sleep phase, or weekend chronotype shifts that destabilize mood. We pair tracker data with weekly sleep diaries and, when clinically indicated, refer for in-lab polysomnography to rule out sleep apnea or REM behavior disorder. Objective data lets us iterate on the treatment plan with precision.

Pharmacologic sleep aids should be selected based on the underlying mechanism, not used interchangeably, and our psychiatrists at RECO Immersive prescribe them deliberately. Melatonin (0.3 to 1 mg, taken five to six hours before desired sleep) is most useful for circadian phase disorders, jet lag, and delayed sleep phase — not as a sedative. Trazodone (25 to 100 mg) is widely used off-label for sleep due to its histaminergic action and minimal dependence risk, making it a common choice when depression and insomnia coexist. Z-drugs like zolpidem and benzodiazepine receptor agonists are reserved for short-term use given dependence and rebound insomnia risk. Newer dual orexin receptor antagonists (suvorexant, lemborexant) are an option for chronic insomnia with fewer next-day effects. Choice always follows the clinical picture.